Thanks for choosing mmm-online.com Sign up for your FREE account now and join the thousands of other healthcare marketing professionals who rely on us for all the latest industry news and innovative ideas for direct and digital strategy. Simply fill out the fields below.

Keep me logged in Forgot your password?

Please wait...

Please wait...

Business Briefs

Business briefs: Alexion, AMA, Eli Lilly

June 19, 2013

Alexion plans on moving into new HQ in 2015, AMA declares obesity is a disease, FDA looks into Zyprexa patient deaths
 

Business briefs: Medtronic, AMA, Komen, GSK, Lilly, AZN

June 18, 2013

Studies undercut Medtronic spine treatment benefit, AMA wars over obesity classification, Komen gets a new CEO, GSK offloads thrombosis meds, Lilly gains diabetes treatment, AZN chooses new site
 

Business briefs: Novo Nordisk, Eli Lilly, Merck

June 17, 2013

Analysts say Novo Nordisk's Victoza should brace for Eli Lilly competition; Lilly halts an Alzheimer's study; and Japan reverses its HPV vaccination stance.
 

Business briefs: Medscape, Livestrong, ACA, Lilly

June 13, 2013

Medscape asked and doctors shared what they hate about most medical apps, Livestrong merch hits the clearance rack, healthcare reform savings begin to surface, Lilly releases early RA drug trial results
 

Business briefs: Boehringer Ingelheim, Teva, Medicare

June 12, 2013

Good and bad news about Pradaxa; Plan B decision not deemed a big threat to Teva's sales; Study says Medicare patients more likely to receive brand-name medications than VA patients
 

Business briefs: GSK, DOJ, Sanofi, Flashpoint Medica

June 11, 2013

GSK boots Shanghai R&D head over data fabrication; DOJ backs off of Plan B; Sanofi scores approval for new flu vaccine; laurels for Flashpoint Medica's Charlene Prounis
 

Business briefs: Aveo, Dynavax, Gilead, OPDP

June 10, 2013

Aveo CRL says company's kidney drug information is uninterpretable; Dynavax has to find more hepatitis B clinical trial patients; Gilead's hep C drug gets priority status; OPDP slaps Janssen and Sigma Tau with untitled letters.
 

Business briefs: Teva, Celgene, Komen, Apple, OPDP

June 06, 2013

Plan B age limits retained and rejected, Celgene drugs gets expanded indication, Komen cuts back on walks, Apple is policing medical apps, OPDP director's Q&A
 

Business Briefs: Kantar Media, Janssen, Eli Lilly, Boehringer Ingelheim, Sanofi, Aveo

June 05, 2013

Healthcare critics continue to spend on anti-ACA ads; Janssen plunges into the microbiome; Lilly gets adult ADHD indication in UK; Sanofi pulls two drugs; and Aveo lays off 140.
 

Business briefs: Sanofi; Doximity; NYBA

June 04, 2013

Sanofi named Connect & Coach as the winner of its 2013 Data Design Diabetes contest
 

Business briefs: pharma websites among top ten

June 03, 2013

Some pharmas get high marks for website design, and the Senate Finance Committee has DTC deductability marked for "reform"
 

Business briefs: AbbVie, Teva, HIV, Diabetes, iPhone

May 30, 2013

AbbVie lays off 100 R&D staff; Teva looks to expand Copaxone footprint; researchers crack HIV protein code; monitors may be misleading diabetics and a prototype sensor turns iPhones into virus hunters.
 

Business Briefs: Amgen and Astellas; GSK; Teva; Novo; Livestrong

May 29, 2013

Amgen and Astellas team up to take on Japan; GSK acquires Swiss vaccine developer's innovative platform; Ireland makes generic switches easier; Novo backs wet AMD therapy; Nike ditches Livestrong
 

Business briefs: AbbVie, AstraZeneca, Valeant, Merck, Novo Nordisk

May 28, 2013

AbbVie's Niaspan pricing gets a hard look; AstraZeneca buys up heart drug and company; Valeant expands eye care portfolio with B&L; Merck halts Parkinson's study; Novo explores liraglutide weight loss results.
 

Business Briefs: Merck and Forest Labs

May 23, 2013

Merck's proposed insomnia drug scores a thumbs-up from an FDA advisory panel, and long-time Forest Labs CEO Howard Solomon announces his coming retirement.
 

Business briefs: Pfizer, Novartis, Boehringer Ingelheim, Elsevier

May 22, 2013

Pfizer seeks full Zoetis split, Novartis gets another NICE Lucentis indication, BI tussles with the FDA and Elsevier names a Cleveland Clinic doc EIC
 

Business Briefs: inVentiv; Mylan; Royalty Pharma; Pfizer; Edelman

May 21, 2013

inVentiv adds new comms exec; Julie Bowen teams up with Mylan for allergy emergencies; Royalty raises the bid on Elan; Pfizer nixes non-Hodgkin's lymphoma drug in trials.
 

Business briefs: Actavis, Bayer, Oramed, Elan

May 20, 2013

Actavis buys Warner Chilcott, FDA clears oral insulin for testing, Elan swallows AOP Orphan for $340M
 

Business briefs: Pfizer, BMS, CMS, Sanofi

May 16, 2013

Pfizer cuts 136 workers loose in Ireland, BMS is investing in heart failure treatments, CMS has an official new leader, and Sanofi's iBGStar may have a competitor.
 

Business briefs: Bayer, FDA, Ranbaxy

May 15, 2013

Bayer's prostate cancer drug clears FDA three months early; a House committee is pressing the regulator for employment transparancy; and Ranbaxy takes a multi-million dollar hit over violations
 
 Subscribe to the RSS for this page  [view all our RSS feeds here]
  

Web Exclusive

What NOT to say to an MS Patient

Dorothy Wetzel June 07, 2013

It is often hard to find the right words when talking to a patient, friend or family member with MS. Even with training and awareness of the disease, we often blurt out something we think is innocuous only to find out later that we have deeply offended. The Health Activists that Extrovertic spoke to had some suggestions for having positive conversations with someone with MS.
 

2013 Hall of Fame Inductees

An entertaining look at the extraordinary lives and careers of the Medical Advertising Hall of Fame's 2013 inductees: Peter Frishauf, Dorothy Philips and David Labson. Clips produced by JUICE Pharma. 

Slideshows

MAHF 2013: Honors Class

A gallery of images from the 2013 Medical Advertising Hall of Fame induction dinner
 
Popular Topics
Acquisition Adherence Advertising American Medical Association App Cardiovascular Clinical Trial Diabetes FDA Generic Generic Drugs Health Affairs Healthcare Reform Journal Articles Layoffs Mobile Obesity Oncology OPDP Patent Cliff Patents Research & Development Rheumatology Social Media Women's Health

Topics

Consumer
Continuing Medical Education (CME)
Digital
Direct to Consumer
Direct to Patient
Downsize
Education & Awareness
FDA
Label
Legal
Online
Over the Counter
Promotion
Public Relations
Sales Force
Trend

Sectors

Agency
Biotech
Government
Media
Pharmaceutical
Suppliers & Vendors

Verticals

Business
Marketing & Communications
Regulatory
Research & Development

Events

Awards

Archives

Issue Archive
Sitemap
 

© 2013 Haymarket Media, Inc.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions